Company Overview
Centene Corporation functions as a managed care company dedicated to providing programs and services to under-insured families and commercial organizations across the United States. The company operates through four distinct segments, including Medicaid, Medicare, Commercial, and Other, with the Medicaid segment specifically offering temporary assistance to eligible populations. This entity operates within the Healthcare sector and the Healthcare Plans industry, positioning itself as a key provider of health insurance coverage for vulnerable demographics and commercial entities. In terms of scale, the company holds a market capitalization of $17.49B and generates annual revenue of $176.15B while employing a workforce of 61,100 individuals. These figures indicate that Centene commands a substantial position in the healthcare insurance landscape, reflecting a massive operational footprint that supports a significant number of beneficiaries and requires a complex infrastructure to manage care delivery and claims processing.
Financial Health
The company reports a trailing twelve-month revenue of $176.15B, yet it recorded a net income of -$6,673,999,872, creating a stark gap between top-line revenue and bottom-line profitability. This significant disparity reveals a highly leveraged cost structure where expenses, including claims payments and operational overhead, substantially outpace net earnings on a GAAP basis. However, the company generates an EBITDA of $2.56B, suggesting that core operating cash generation remains positive despite the reported net loss. Free cash flow stands at $5.05B, which provides the company with considerable financial flexibility to fund operations, invest in technology, or manage capital structure without relying on external financing. The gross margin is recorded at 10.5%, indicating that the company retains a specific portion of revenue after direct costs, while the operating margin sits at -1.9% and the profit margin at -3.8%, signaling that overhead and administrative expenses are consuming a large share of the operating income. On the balance sheet, total cash resources of $20.32B exceed total debt obligations of $18.16B, though the debt-to-equity ratio is 90.56%, indicating a highly leveraged capital structure relative to shareholder equity. The current ratio is 1.10, which suggests that the company holds just enough current assets to cover its current liabilities, pointing to a tight but manageable short-term liquidity position. Return on equity is reported at -28.7% and return on assets at 1.0%, metrics that reveal challenges in generating returns for shareholders and utilizing total assets efficiently given the net loss position.
Valuation Assessment
Valuation metrics for Centene show a trailing P/E ratio of N/A due to the net loss, while the forward P/E is 8.73, implying that the market prices the stock based on expected future earnings normalization rather than current performance. The price-to-book ratio is 0.88, indicating that the market values the company at less than its book value, which often reflects skepticism regarding the sustainability of current assets or expectations of future losses. Alternative valuation measures include a price-to-sales ratio of 0.10 and an EV/EBITDA of 6.03, suggesting that the stock is priced at a significant discount relative to its revenue and adjusted earnings before interest, taxes, depreciation, and amortization. The stock has traded between a 52-week high of $66.03 and a 52-week low of $25.08, placing the current valuation context within this wide historical range to assess potential mean reversion or continued volatility. The beta is 0.46, which indicates that the stock's price volatility is less than 50% of the broader market's movements, suggesting a defensive characteristic relative to the overall equity market despite the healthcare sector's general stability.
Growth & Income
Revenue growth year-over-year is recorded at 23.2%, demonstrating a robust expansion in the top line, while earnings growth is N/A due to the current net loss, meaning earnings are not growing in the traditional sense but rather reflecting ongoing structural adjustments. Because the company does not pay a dividend, with a dividend yield of N/A and a payout ratio of 0.0%, it retains all earnings to reinvest into growth initiatives rather than distributing cash to shareholders. The absence of a dividend payout confirms that the company prioritizes capital allocation toward business expansion and operational scaling over income generation for investors. Overall, the growth and income profile is characterized by strong top-line expansion coupled with a lack of current profitability and dividend distribution, creating a scenario where shareholder returns are derived solely from capital appreciation potential.